ask="44.50"
ask_size="2400"
average_daily_volume="1095440"
bid="37.50"
bid_size="100"
book_value="4.05"
change="+0.92"
change_from_200_day_moving_average="-3.74"
change_from_50_day_moving_average="0.87"
change_from_52_week_high="-12.70"
change_From_52_week_low="10.27"
change_in_percent="+2.22%"
close="42.45"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-2.13"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="85678000"
high="44.00"
high_52_weeks="55.15"
last_trade_date="2/15/2017"
last_trade_price="42.45"
last_trade_size="46871"
last_trade_time="4:00pm"
low="41.62"
low_52_weeks="32.18"
market_capitalization="3.69B"
moving_average_200_day="46.19"
moving_average_50_day="41.58"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="66.58"
open="42.44"
pe_ratio="N/A"
peg_ratio="0.54"
percent_change_from_200_day_moving_average="-8.10%"
percent_change_from_50_day_moving_average="+2.10%"
percent_change_from_52_week_high="-23.03%"
percent_change_from_52_week_low="+31.91%"
previous_close="41.53"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.26"
price_per_sales="240.52"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="1030910"
weeks_range_52="32.18 - 55.15"
